ESSILOR (EPA:EL) ESSILOR supports the planned friendly bid for Sperian Protection
Transparency directive : regulatory news
31/03/2010 15:28
Click here to download pdf version
News ReleaseEssilor supports the planned friendly bid for Sperian Protection
Charenton-le-Pont, France (March 31, 2010) - Essilor International announced
today that it has signed an agreement with the Cinven Investment Fund and Mrs.
Ginette Dalloz concerning Essilor's 15.05% stake (23.21% voting rights) in
Sperian Protection. According to the terms of the deal and subject to certain
conditions, Cinven will launch a cash tender offer for Sperian Protection
through a holding company (Menelas France) under its control.
Essilor has agreed to tender all of its shares in Sperian Protection to Menelas
France, based on the offered price per share, provided that, at the end of the
offer period, Menelas France holds 57% of Sperian Protection's capital,
including shares tendered by Essilor and Mrs. Ginette Dalloz (directly and
indirectly).
By providing the resources needed to pursue growth opportunities when they
arise, Essilor believes this transaction is fully aligned with Sperian
Protection's overall development strategy.
The world leader in ophthalmic optical products, Essilor International
researches, develops, manufactures and markets around the world a wide range of
lenses to correct myopia, hyperopia, presbyopia and astigmatism. Its flagship
brands are Varilux(r), Crizal(r), Essilor(r), Definity(r) and Xperio(TM).
Based in France, the company reported consolidated revenue of more than
EUR3.2 billion in 2009, with 34,700 employees and operations in 100 countries.
For more information, please visit www.essilor.com.
The Essilor share trades on the NYSE Euronext Paris market and is included in
the CAC 40 index.
Codes and symbols: ISIN: FR FR0000121667; Reuters: ESSI.PA; Bloomberg: EI:FP.
Investor Relations and Financial Communications
Véronique Gillet - Sébastien Leroy
Phone: +33 (0)1 49 77 42 16
www.essilor.com
ESSILOR's latest news
21/02/2024 07:00
27/09/2023 20:00
29/08/2023 18:00
13/07/2023 18:00
29/06/2023 08:00
17/05/2023 18:00
10/05/2023 08:00
14/04/2023 18:34
22/02/2023 18:03
13/02/2023 18:47
Other stories
18/05/2024 04:03
17/05/2024 22:34
18/05/2024 07:34
17/05/2024 19:16
17/05/2024 21:48
17/05/2024 13:06
17/05/2024 19:08
17/05/2024 19:29
17/05/2024 23:20
17/05/2024 23:17
17/05/2024 22:50
18/05/2024 01:38
17/05/2024 16:26
17/05/2024 23:17
17/05/2024 21:56
17/05/2024 20:56
17/05/2024 13:44
17/05/2024 20:25
17/05/2024 22:22
17/05/2024 20:08
16/05/2024 23:30
17/05/2024 23:03
18/05/2024 07:59
18/05/2024 00:33
17/05/2024 17:37
18/05/2024 07:00
18/05/2024 03:31
18/05/2024 01:55
17/05/2024 22:54
17/05/2024 22:59
17/05/2024 01:00
17/05/2024 23:23
17/05/2024 22:00
17/05/2024 07:14
17/05/2024 22:10
17/05/2024 20:36
17/05/2024 17:11
17/05/2024 16:41